Skip to main content
Top
Published in: BMC Cancer 1/2009

Open Access 01-12-2009 | Research article

Selenium enrichment of broccoli sprout extract increases chemosensitivity and apoptosis of LNCaP prostate cancer cells

Authors: Rizky Abdulah, Ahmad Faried, Kenji Kobayashi, Chiho Yamazaki, Eka W Suradji, Kazuto Ito, Kazuhiro Suzuki, Masami Murakami, Hiroyuki Kuwano, Hiroshi Koyama

Published in: BMC Cancer | Issue 1/2009

Login to get access

Abstract

Background

Broccoli is a Brassica vegetable that is believed to possess chemopreventive properties. Selenium also shows promise as an anticancer agent. Thus, selenium enrichment of broccoli has the potential to enhance the anticancer properties of broccoli sprouts.

Method

Selenium-enriched broccoli sprouts were prepared using a sodium selenite solution. Their anticancer properties were evaluated in human prostate cancer cell lines and compared with those of a control broccoli sprout extract.

Results

Selenium-enriched broccoli sprouts were superior to normal broccoli sprouts in inhibiting cell proliferation, decreasing prostate-specific antigen secretion, and inducing apoptosis of prostate cancer cells. Furthermore, selenium-enriched broccoli sprouts but, not normal broccoli sprouts, induced a downregulation of the survival Akt/mTOR pathway.

Conclusion

Our results suggest that selenium-enriched broccoli sprouts could potentially be used as an alternative selenium source for prostate cancer prevention and therapy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Abdulah R, Koyama H, Miyazaki K, Nara M, Murakami M: Selenium supplementation and blood rheological improvement in Japanese adults. Biol Trace Elem Res. 2006, 112 (1): 87-96. 10.1385/BTER:112:1:87.CrossRefPubMed Abdulah R, Koyama H, Miyazaki K, Nara M, Murakami M: Selenium supplementation and blood rheological improvement in Japanese adults. Biol Trace Elem Res. 2006, 112 (1): 87-96. 10.1385/BTER:112:1:87.CrossRefPubMed
2.
go back to reference Abdulah R, Katsuya Y, Kobayashi K, Nakazawa M, Nara M, Murakami M, Koyama H: Effect of sodium selenite supplementation on the levels of prostacyclin I(2) and thromboxane A(2) in human. Thromb Res. 2007, 119 (3): 305-310. 10.1016/j.thromres.2006.02.005.CrossRefPubMed Abdulah R, Katsuya Y, Kobayashi K, Nakazawa M, Nara M, Murakami M, Koyama H: Effect of sodium selenite supplementation on the levels of prostacyclin I(2) and thromboxane A(2) in human. Thromb Res. 2007, 119 (3): 305-310. 10.1016/j.thromres.2006.02.005.CrossRefPubMed
3.
go back to reference Lymbury R, Tinggi U, Griffiths L, Rosenfeldt F, Perkins AV: Selenium status of the Australian population: effect of age, gender and cardiovascular disease. Biol Trace Elem Res. 2008, 126 (Suppl 1): S1-10. 10.1007/s12011-008-8208-6.CrossRefPubMed Lymbury R, Tinggi U, Griffiths L, Rosenfeldt F, Perkins AV: Selenium status of the Australian population: effect of age, gender and cardiovascular disease. Biol Trace Elem Res. 2008, 126 (Suppl 1): S1-10. 10.1007/s12011-008-8208-6.CrossRefPubMed
4.
go back to reference Clark LC, Combs GF, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, et al: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA. 1996, 276 (24): 1957-1963. 10.1001/jama.276.24.1957.CrossRefPubMed Clark LC, Combs GF, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, et al: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA. 1996, 276 (24): 1957-1963. 10.1001/jama.276.24.1957.CrossRefPubMed
5.
go back to reference Abdulah R, Miyazaki K, Nakazawa M, Koyama H: Chemical forms of selenium for cancer prevention. J Trace Elem Med Biol. 2005, 19 (2-3): 141-150. 10.1016/j.jtemb.2005.09.003.CrossRefPubMed Abdulah R, Miyazaki K, Nakazawa M, Koyama H: Chemical forms of selenium for cancer prevention. J Trace Elem Med Biol. 2005, 19 (2-3): 141-150. 10.1016/j.jtemb.2005.09.003.CrossRefPubMed
6.
go back to reference Peters U, Takata Y: Selenium and the prevention of prostate and colorectal cancer. Mol Nutr Food Res. 2008, 52 (11): 1261-1272. 10.1002/mnfr.200800103.CrossRefPubMedPubMedCentral Peters U, Takata Y: Selenium and the prevention of prostate and colorectal cancer. Mol Nutr Food Res. 2008, 52 (11): 1261-1272. 10.1002/mnfr.200800103.CrossRefPubMedPubMedCentral
7.
go back to reference Alfthan G, Xu GL, Tan WH, Aro A, Wu J, Yang YX, Liang WS, Xue WL, Kong LH: Selenium supplementation of children in a selenium-deficient area in China: blood selenium levels and glutathione peroxidase activities. Biol Trace Elem Res. 2000, 73 (2): 113-125. 10.1385/BTER:73:2:113.CrossRefPubMed Alfthan G, Xu GL, Tan WH, Aro A, Wu J, Yang YX, Liang WS, Xue WL, Kong LH: Selenium supplementation of children in a selenium-deficient area in China: blood selenium levels and glutathione peroxidase activities. Biol Trace Elem Res. 2000, 73 (2): 113-125. 10.1385/BTER:73:2:113.CrossRefPubMed
8.
go back to reference Sakoda LC, Graubard BI, Evans AA, London WT, Lin WY, Shen FM, McGlynn KA: Toenail selenium and risk of hepatocellular carcinoma mortality in Haimen City, China. Int J Cancer. 2005, 115 (4): 618-624. 10.1002/ijc.20937.CrossRefPubMed Sakoda LC, Graubard BI, Evans AA, London WT, Lin WY, Shen FM, McGlynn KA: Toenail selenium and risk of hepatocellular carcinoma mortality in Haimen City, China. Int J Cancer. 2005, 115 (4): 618-624. 10.1002/ijc.20937.CrossRefPubMed
9.
go back to reference Zou K, Liu G, Wu T, Du L: Selenium for preventing Kashin-Beck osteoarthropathy in children: a meta-analysis. Osteoarthritis Cartilage. 2009, 17 (2): 144-151. 10.1016/j.joca.2008.06.011.CrossRefPubMed Zou K, Liu G, Wu T, Du L: Selenium for preventing Kashin-Beck osteoarthropathy in children: a meta-analysis. Osteoarthritis Cartilage. 2009, 17 (2): 144-151. 10.1016/j.joca.2008.06.011.CrossRefPubMed
10.
go back to reference Hunt JR: Tailoring advice on dietary supplements: an opportunity for dietetics professionals. J Am Diet Assoc. 2002, 102 (12): 1754-1755. 10.1016/S0002-8223(02)90377-9.CrossRefPubMed Hunt JR: Tailoring advice on dietary supplements: an opportunity for dietetics professionals. J Am Diet Assoc. 2002, 102 (12): 1754-1755. 10.1016/S0002-8223(02)90377-9.CrossRefPubMed
11.
go back to reference Rayman MP: The use of high-selenium yeast to raise selenium status: how does it measure up?. Br J Nutr. 2004, 92 (4): 557-573. 10.1079/BJN20041251.CrossRefPubMed Rayman MP: The use of high-selenium yeast to raise selenium status: how does it measure up?. Br J Nutr. 2004, 92 (4): 557-573. 10.1079/BJN20041251.CrossRefPubMed
12.
go back to reference Finley JW, Davis CD, Feng Y: Selenium from high selenium broccoli protects rats from colon cancer. J Nutr. 2000, 130 (9): 2384-2389.PubMed Finley JW, Davis CD, Feng Y: Selenium from high selenium broccoli protects rats from colon cancer. J Nutr. 2000, 130 (9): 2384-2389.PubMed
13.
go back to reference Davis CD, Zeng H, Finley JW: Selenium-enriched broccoli decreases intestinal tumorigenesis in multiple intestinal neoplasia mice. J Nutr. 2002, 132 (2): 307-309.PubMed Davis CD, Zeng H, Finley JW: Selenium-enriched broccoli decreases intestinal tumorigenesis in multiple intestinal neoplasia mice. J Nutr. 2002, 132 (2): 307-309.PubMed
14.
go back to reference Zeng H, Davis CD, Finley JW: Effect of selenium-enriched broccoli diet on differential gene expression in min mouse liver(1,2). J Nutr Biochem. 2003, 14 (4): 227-231. 10.1016/S0955-2863(03)00005-6.CrossRefPubMed Zeng H, Davis CD, Finley JW: Effect of selenium-enriched broccoli diet on differential gene expression in min mouse liver(1,2). J Nutr Biochem. 2003, 14 (4): 227-231. 10.1016/S0955-2863(03)00005-6.CrossRefPubMed
15.
go back to reference Zhang Y, Talalay P, Cho CG, Posner GH: A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci USA. 1992, 89 (6): 2399-2403. 10.1073/pnas.89.6.2399.CrossRefPubMedPubMedCentral Zhang Y, Talalay P, Cho CG, Posner GH: A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci USA. 1992, 89 (6): 2399-2403. 10.1073/pnas.89.6.2399.CrossRefPubMedPubMedCentral
16.
go back to reference Shankar S, Ganapathy S, Srivastava RK: Sulforaphane enhances the therapeutic potential of TRAIL in prostate cancer orthotopic model through regulation of apoptosis, metastasis, and angiogenesis. Clin Cancer Res. 2008, 14 (21): 6855-6866. 10.1158/1078-0432.CCR-08-0903.CrossRefPubMed Shankar S, Ganapathy S, Srivastava RK: Sulforaphane enhances the therapeutic potential of TRAIL in prostate cancer orthotopic model through regulation of apoptosis, metastasis, and angiogenesis. Clin Cancer Res. 2008, 14 (21): 6855-6866. 10.1158/1078-0432.CCR-08-0903.CrossRefPubMed
17.
go back to reference Ellis DR, Salt DE: Plants, selenium and human health. Curr Opin Plant Biol. 2003, 6 (3): 273-279. 10.1016/S1369-5266(03)00030-X.CrossRefPubMed Ellis DR, Salt DE: Plants, selenium and human health. Curr Opin Plant Biol. 2003, 6 (3): 273-279. 10.1016/S1369-5266(03)00030-X.CrossRefPubMed
18.
go back to reference Ellis DR, Sors TG, Brunk DG, Albrecht C, Orser C, Lahner B, Wood KV, Harris HH, Pickering IJ, Salt DE: Production of Se-methylselenocysteine in transgenic plants expressing selenocysteine methyltransferase. BMC Plant Biol. 2004, 4: 1-10.1186/1471-2229-4-1.CrossRefPubMedPubMedCentral Ellis DR, Sors TG, Brunk DG, Albrecht C, Orser C, Lahner B, Wood KV, Harris HH, Pickering IJ, Salt DE: Production of Se-methylselenocysteine in transgenic plants expressing selenocysteine methyltransferase. BMC Plant Biol. 2004, 4: 1-10.1186/1471-2229-4-1.CrossRefPubMedPubMedCentral
19.
go back to reference Medina D, Thompson H, Ganther H, Ip C: Se-methylselenocysteine: a new compound for chemoprevention of breast cancer. Nutr Cancer. 2001, 40 (1): 12-17. 10.1207/S15327914NC401_5.CrossRefPubMed Medina D, Thompson H, Ganther H, Ip C: Se-methylselenocysteine: a new compound for chemoprevention of breast cancer. Nutr Cancer. 2001, 40 (1): 12-17. 10.1207/S15327914NC401_5.CrossRefPubMed
20.
go back to reference Ip C, Dong Y, Ganther HE: New concepts in selenium chemoprevention. Cancer Metastasis Rev. 2002, 21 (3-4): 281-289. 10.1023/A:1021263027659.CrossRefPubMed Ip C, Dong Y, Ganther HE: New concepts in selenium chemoprevention. Cancer Metastasis Rev. 2002, 21 (3-4): 281-289. 10.1023/A:1021263027659.CrossRefPubMed
21.
go back to reference Matusheski NV, Juvik JA, Jeffery EH: Heating decreases epithiospecifier protein activity and increases sulforaphane formation in broccoli. Phytochemistry. 2004, 65 (9): 1273-1281. 10.1016/j.phytochem.2004.04.013.CrossRefPubMed Matusheski NV, Juvik JA, Jeffery EH: Heating decreases epithiospecifier protein activity and increases sulforaphane formation in broccoli. Phytochemistry. 2004, 65 (9): 1273-1281. 10.1016/j.phytochem.2004.04.013.CrossRefPubMed
22.
go back to reference Nakagawa K, Umeda T, Higuchi O, Tsuzuki T, Suzuki T, Miyazawa T: Evaporative light-scattering analysis of sulforaphane in broccoli samples: Quality of broccoli products regarding sulforaphane contents. J Agric Food Chem. 2006, 54 (7): 2479-2483. 10.1021/jf051823g.CrossRefPubMed Nakagawa K, Umeda T, Higuchi O, Tsuzuki T, Suzuki T, Miyazawa T: Evaporative light-scattering analysis of sulforaphane in broccoli samples: Quality of broccoli products regarding sulforaphane contents. J Agric Food Chem. 2006, 54 (7): 2479-2483. 10.1021/jf051823g.CrossRefPubMed
23.
go back to reference Tang L, Zhang Y, Jobson HE, Li J, Stephenson KK, Wade KL, Fahey JW: Potent activation of mitochondria-mediated apoptosis and arrest in S and M phases of cancer cells by a broccoli sprout extract. Mol Cancer Ther. 2006, 5 (4): 935-944. 10.1158/1535-7163.MCT-05-0476.CrossRefPubMed Tang L, Zhang Y, Jobson HE, Li J, Stephenson KK, Wade KL, Fahey JW: Potent activation of mitochondria-mediated apoptosis and arrest in S and M phases of cancer cells by a broccoli sprout extract. Mol Cancer Ther. 2006, 5 (4): 935-944. 10.1158/1535-7163.MCT-05-0476.CrossRefPubMed
24.
go back to reference Dinkova-Kostova AT, Jenkins SN, Fahey JW, Ye L, Wehage SL, Liby KT, Stephenson KK, Wade KL, Talalay P: Protection against UV-light-induced skin carcinogenesis in SKH-1 high-risk mice by sulforaphane-containing broccoli sprout extracts. Cancer Lett. 2006, 240 (2): 243-252. 10.1016/j.canlet.2005.09.012.CrossRefPubMed Dinkova-Kostova AT, Jenkins SN, Fahey JW, Ye L, Wehage SL, Liby KT, Stephenson KK, Wade KL, Talalay P: Protection against UV-light-induced skin carcinogenesis in SKH-1 high-risk mice by sulforaphane-containing broccoli sprout extracts. Cancer Lett. 2006, 240 (2): 243-252. 10.1016/j.canlet.2005.09.012.CrossRefPubMed
25.
go back to reference Munday R, Mhawech-Fauceglia P, Munday CM, Paonessa JD, Tang L, Munday JS, Lister C, Wilson P, Fahey JW, Davis W, et al: Inhibition of urinary bladder carcinogenesis by broccoli sprouts. Cancer Res. 2008, 68 (5): 1593-1600. 10.1158/0008-5472.CAN-07-5009.CrossRefPubMed Munday R, Mhawech-Fauceglia P, Munday CM, Paonessa JD, Tang L, Munday JS, Lister C, Wilson P, Fahey JW, Davis W, et al: Inhibition of urinary bladder carcinogenesis by broccoli sprouts. Cancer Res. 2008, 68 (5): 1593-1600. 10.1158/0008-5472.CAN-07-5009.CrossRefPubMed
26.
go back to reference Kolonel LN, Hankin JH, Whittemore AS, Wu AH, Gallagher RP, Wilkens LR, John EM, Howe GR, Dreon DM, West DW, et al: Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. Cancer Epidemiol Biomarkers Prev. 2000, 9 (8): 795-804.PubMed Kolonel LN, Hankin JH, Whittemore AS, Wu AH, Gallagher RP, Wilkens LR, John EM, Howe GR, Dreon DM, West DW, et al: Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. Cancer Epidemiol Biomarkers Prev. 2000, 9 (8): 795-804.PubMed
27.
go back to reference Sugihara S, Kondo M, Chihara Y, Yuji M, Hattori H, Yoshida M: Preparation of selenium-enriched sprouts and identification of their selenium species by high-performance liquid chromatography-inductively coupled plasma mass spectrometry. Biosci Biotechnol Biochem. 2004, 68 (1): 193-199. 10.1271/bbb.68.193.CrossRefPubMed Sugihara S, Kondo M, Chihara Y, Yuji M, Hattori H, Yoshida M: Preparation of selenium-enriched sprouts and identification of their selenium species by high-performance liquid chromatography-inductively coupled plasma mass spectrometry. Biosci Biotechnol Biochem. 2004, 68 (1): 193-199. 10.1271/bbb.68.193.CrossRefPubMed
28.
go back to reference Abdulah R, Miyazaki K, Nakazawa M, Koyama H: Low contribution of rice and vegetables to the daily intake of selenium in Japan. Int J Food Sci Nutr. 2005, 56 (7): 463-471. 10.1080/09637480500490640.CrossRefPubMed Abdulah R, Miyazaki K, Nakazawa M, Koyama H: Low contribution of rice and vegetables to the daily intake of selenium in Japan. Int J Food Sci Nutr. 2005, 56 (7): 463-471. 10.1080/09637480500490640.CrossRefPubMed
29.
go back to reference Liang H, Yuan Q, Xiao Q: Purification of sulforaphane from Brassica oleracea seed meal using low-pressure column chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 2005, 828 (1-2): 91-96. 10.1016/j.jchromb.2005.09.041.CrossRefPubMed Liang H, Yuan Q, Xiao Q: Purification of sulforaphane from Brassica oleracea seed meal using low-pressure column chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 2005, 828 (1-2): 91-96. 10.1016/j.jchromb.2005.09.041.CrossRefPubMed
30.
go back to reference Sashiyama H, Shino Y, Sakao S, Shimada H, Kobayashi S, Ochiai T, Shirasawa H: Alteration of integrin expression relates to malignant progression of human papillomavirus-immortalized esophageal keratinocytes. Cancer Lett. 2002, 177 (1): 21-28. 10.1016/S0304-3835(01)00771-6.CrossRefPubMed Sashiyama H, Shino Y, Sakao S, Shimada H, Kobayashi S, Ochiai T, Shirasawa H: Alteration of integrin expression relates to malignant progression of human papillomavirus-immortalized esophageal keratinocytes. Cancer Lett. 2002, 177 (1): 21-28. 10.1016/S0304-3835(01)00771-6.CrossRefPubMed
31.
go back to reference Faried A, Faried LS, Kimura H, Sohda M, Nakajima M, Miyazaki T, Kato H, Kanuma T, Kuwano H: Differential sensitivity of paclitaxel-induced apoptosis in human esophageal squamous cell carcinoma cell lines. Cancer Chemother Pharmacol. 2006, 57 (3): 301-308. 10.1007/s00280-005-0038-z.CrossRefPubMed Faried A, Faried LS, Kimura H, Sohda M, Nakajima M, Miyazaki T, Kato H, Kanuma T, Kuwano H: Differential sensitivity of paclitaxel-induced apoptosis in human esophageal squamous cell carcinoma cell lines. Cancer Chemother Pharmacol. 2006, 57 (3): 301-308. 10.1007/s00280-005-0038-z.CrossRefPubMed
32.
go back to reference Cho SD, Jiang C, Malewicz B, Dong Y, Young CY, Kang KS, Lee YS, Ip C, Lu J: Methyl selenium metabolites decrease prostate-specific antigen expression by inducing protein degradation and suppressing androgen-stimulated transcription. Mol Cancer Ther. 2004, 3 (5): 605-611.PubMed Cho SD, Jiang C, Malewicz B, Dong Y, Young CY, Kang KS, Lee YS, Ip C, Lu J: Methyl selenium metabolites decrease prostate-specific antigen expression by inducing protein degradation and suppressing androgen-stimulated transcription. Mol Cancer Ther. 2004, 3 (5): 605-611.PubMed
33.
go back to reference R Development Core Team: R: A language and environment for statistical computing. 2009, Vienna: R Foundation for Statistical Computing R Development Core Team: R: A language and environment for statistical computing. 2009, Vienna: R Foundation for Statistical Computing
34.
go back to reference Takahashi T, Hoshi S, Satoh M, Kaneda T, Suzuki KI, Nakagawara KI, Orikasa S: The study of PSA gene expression on urogenital cell lines. Int J Urol. 1999, 6 (10): 526-531. 10.1046/j.1442-2042.1999.00104.x.CrossRefPubMed Takahashi T, Hoshi S, Satoh M, Kaneda T, Suzuki KI, Nakagawara KI, Orikasa S: The study of PSA gene expression on urogenital cell lines. Int J Urol. 1999, 6 (10): 526-531. 10.1046/j.1442-2042.1999.00104.x.CrossRefPubMed
35.
go back to reference Nguyen DM, Chen GA, Reddy R, Tsai W, Schrump WD, Cole G, Schrump DS: Potentiation of paclitaxel cytotoxicity in lung and esophageal cancer cells by pharmacologic inhibition of the phosphoinositide 3-kinase/protein kinase B (Akt)-mediated signaling pathway. J Thorac Cardiovasc Surg. 2004, 127 (2): 365-375. 10.1016/j.jtcvs.2003.09.033.CrossRefPubMed Nguyen DM, Chen GA, Reddy R, Tsai W, Schrump WD, Cole G, Schrump DS: Potentiation of paclitaxel cytotoxicity in lung and esophageal cancer cells by pharmacologic inhibition of the phosphoinositide 3-kinase/protein kinase B (Akt)-mediated signaling pathway. J Thorac Cardiovasc Surg. 2004, 127 (2): 365-375. 10.1016/j.jtcvs.2003.09.033.CrossRefPubMed
36.
go back to reference Faried LS, Faried A, Kanuma T, Nakazato T, Tamura T, Kuwano H, Minegishi T: Inhibition of the mammalian target of rapamycin (mTOR) by rapamycin increases chemosensitivity of CaSki cells to paclitaxel. Eur J Cancer. 2006, 42 (7): 934-947. 10.1016/j.ejca.2005.12.018.CrossRefPubMed Faried LS, Faried A, Kanuma T, Nakazato T, Tamura T, Kuwano H, Minegishi T: Inhibition of the mammalian target of rapamycin (mTOR) by rapamycin increases chemosensitivity of CaSki cells to paclitaxel. Eur J Cancer. 2006, 42 (7): 934-947. 10.1016/j.ejca.2005.12.018.CrossRefPubMed
37.
go back to reference Faried A, Kurnia D, Faried LS, Usman N, Miyazaki T, Kato H, Kuwano H: Anticancer effects of gallic acid isolated from Indonesian herbal medicine, Phaleria macrocarpa (Scheff.) Boerl, on human cancer cell lines. Int J Oncol. 2007, 30 (3): 605-613.PubMed Faried A, Kurnia D, Faried LS, Usman N, Miyazaki T, Kato H, Kuwano H: Anticancer effects of gallic acid isolated from Indonesian herbal medicine, Phaleria macrocarpa (Scheff.) Boerl, on human cancer cell lines. Int J Oncol. 2007, 30 (3): 605-613.PubMed
38.
go back to reference Brown TA, Shrift A: Exclusion of Selenium from Proteins of Selenium-Tolerant Astragalus Species. Plant Physiol. 1981, 67 (5): 1051-1053. 10.1104/pp.67.5.1051.CrossRefPubMedPubMedCentral Brown TA, Shrift A: Exclusion of Selenium from Proteins of Selenium-Tolerant Astragalus Species. Plant Physiol. 1981, 67 (5): 1051-1053. 10.1104/pp.67.5.1051.CrossRefPubMedPubMedCentral
39.
go back to reference Wang Y, Bock A, Neuhierl B: Acquisition of selenium tolerance by a selenium non-accumulating Astragalus species via selection. Biofactors. 1999, 9 (1): 3-10. 10.1002/biof.5520090102.CrossRefPubMed Wang Y, Bock A, Neuhierl B: Acquisition of selenium tolerance by a selenium non-accumulating Astragalus species via selection. Biofactors. 1999, 9 (1): 3-10. 10.1002/biof.5520090102.CrossRefPubMed
40.
go back to reference Foster SJ, Kraus RJ, Ganther HE: The metabolism of selenomethionine, Se-methylselenocysteine, their selenonium derivatives, and trimethylselenonium in the rat. Arch Biochem Biophys. 1986, 251 (1): 77-86. 10.1016/0003-9861(86)90053-6.CrossRefPubMed Foster SJ, Kraus RJ, Ganther HE: The metabolism of selenomethionine, Se-methylselenocysteine, their selenonium derivatives, and trimethylselenonium in the rat. Arch Biochem Biophys. 1986, 251 (1): 77-86. 10.1016/0003-9861(86)90053-6.CrossRefPubMed
41.
go back to reference Yeo JK, Cha SD, Cho CH, Kim SP, Cho JW, Baek WK, Suh MH, Kwon TK, Park JW, Suh SI: Se-methylselenocysteine induces apoptosis through caspase activation and Bax cleavage mediated by calpain in SKOV-3 ovarian cancer cells. Cancer Lett. 2002, 182 (1): 83-92. 10.1016/S0304-3835(02)00075-7.CrossRefPubMed Yeo JK, Cha SD, Cho CH, Kim SP, Cho JW, Baek WK, Suh MH, Kwon TK, Park JW, Suh SI: Se-methylselenocysteine induces apoptosis through caspase activation and Bax cleavage mediated by calpain in SKOV-3 ovarian cancer cells. Cancer Lett. 2002, 182 (1): 83-92. 10.1016/S0304-3835(02)00075-7.CrossRefPubMed
42.
go back to reference Cao S, Durrani FA, Rustum YM: Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts. Clin Cancer Res. 2004, 10 (7): 2561-2569. 10.1158/1078-0432.CCR-03-0268.CrossRefPubMed Cao S, Durrani FA, Rustum YM: Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts. Clin Cancer Res. 2004, 10 (7): 2561-2569. 10.1158/1078-0432.CCR-03-0268.CrossRefPubMed
43.
go back to reference Lee SO, Yeon Chun J, Nadiminty N, Trump DL, Ip C, Dong Y, Gao AC: Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA). Prostate. 2006, 66 (10): 1070-1075. 10.1002/pros.20329.CrossRefPubMed Lee SO, Yeon Chun J, Nadiminty N, Trump DL, Ip C, Dong Y, Gao AC: Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA). Prostate. 2006, 66 (10): 1070-1075. 10.1002/pros.20329.CrossRefPubMed
44.
go back to reference Brooks JD, Paton VG, Vidanes G: Potent induction of phase 2 enzymes in human prostate cells by sulforaphane. Cancer Epidemiol Biomarkers Prev. 2001, 10 (9): 949-954.PubMed Brooks JD, Paton VG, Vidanes G: Potent induction of phase 2 enzymes in human prostate cells by sulforaphane. Cancer Epidemiol Biomarkers Prev. 2001, 10 (9): 949-954.PubMed
45.
go back to reference Bhamre S, Sahoo D, Tibshirani R, Dill DL, Brooks JD: Temporal changes in gene expression induced by sulforaphane in human prostate cancer cells. Prostate. 2009, 69 (2): 181-190. 10.1002/pros.20869.CrossRefPubMedPubMedCentral Bhamre S, Sahoo D, Tibshirani R, Dill DL, Brooks JD: Temporal changes in gene expression induced by sulforaphane in human prostate cancer cells. Prostate. 2009, 69 (2): 181-190. 10.1002/pros.20869.CrossRefPubMedPubMedCentral
46.
go back to reference Myzak MC, Tong P, Dashwood WM, Dashwood RH, Ho E: Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Exp Biol Med (Maywood). 2007, 232 (2): 227-234. Myzak MC, Tong P, Dashwood WM, Dashwood RH, Ho E: Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Exp Biol Med (Maywood). 2007, 232 (2): 227-234.
47.
go back to reference Zhang Y, Munday R, Jobson HE, Munday CM, Lister C, Wilson P, Fahey JW, Mhawech-Fauceglia P: Induction of GST and NQO1 in cultured bladder cells and in the urinary bladders of rats by an extract of broccoli (Brassica oleracea italica) sprouts. J Agric Food Chem. 2006, 54 (25): 9370-9376. 10.1021/jf062109h.CrossRefPubMed Zhang Y, Munday R, Jobson HE, Munday CM, Lister C, Wilson P, Fahey JW, Mhawech-Fauceglia P: Induction of GST and NQO1 in cultured bladder cells and in the urinary bladders of rats by an extract of broccoli (Brassica oleracea italica) sprouts. J Agric Food Chem. 2006, 54 (25): 9370-9376. 10.1021/jf062109h.CrossRefPubMed
48.
go back to reference Dinkova-Kostova AT, Fahey JW, Wade KL, Jenkins SN, Shapiro TA, Fuchs EJ, Kerns ML, Talalay P: Induction of the phase 2 response in mouse and human skin by sulforaphane-containing broccoli sprout extracts. Cancer Epidemiol Biomarkers Prev. 2007, 16 (4): 847-851. 10.1158/1055-9965.EPI-06-0934.CrossRefPubMed Dinkova-Kostova AT, Fahey JW, Wade KL, Jenkins SN, Shapiro TA, Fuchs EJ, Kerns ML, Talalay P: Induction of the phase 2 response in mouse and human skin by sulforaphane-containing broccoli sprout extracts. Cancer Epidemiol Biomarkers Prev. 2007, 16 (4): 847-851. 10.1158/1055-9965.EPI-06-0934.CrossRefPubMed
49.
go back to reference Traka M, Gasper AV, Melchini A, Bacon JR, Needs PW, Frost V, Chantry A, Jones AM, Ortori CA, Barrett DA, et al: Broccoli consumption interacts with GSTM1 to perturb oncogenic signalling pathways in the prostate. PLoS One. 2008, 3 (7): e2568-10.1371/journal.pone.0002568.CrossRefPubMedPubMedCentral Traka M, Gasper AV, Melchini A, Bacon JR, Needs PW, Frost V, Chantry A, Jones AM, Ortori CA, Barrett DA, et al: Broccoli consumption interacts with GSTM1 to perturb oncogenic signalling pathways in the prostate. PLoS One. 2008, 3 (7): e2568-10.1371/journal.pone.0002568.CrossRefPubMedPubMedCentral
50.
go back to reference Dong Y, Lee SO, Zhang H, Marshall J, Gao AC, Ip C: Prostate specific antigen expression is down-regulated by selenium through disruption of androgen receptor signaling. Cancer Res. 2004, 64 (1): 19-22. 10.1158/0008-5472.CAN-03-2789.CrossRefPubMed Dong Y, Lee SO, Zhang H, Marshall J, Gao AC, Ip C: Prostate specific antigen expression is down-regulated by selenium through disruption of androgen receptor signaling. Cancer Res. 2004, 64 (1): 19-22. 10.1158/0008-5472.CAN-03-2789.CrossRefPubMed
51.
go back to reference Fahey JW, Zhang Y, Talalay P: Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc Natl Acad Sci USA. 1997, 94 (19): 10367-10372. 10.1073/pnas.94.19.10367.CrossRefPubMedPubMedCentral Fahey JW, Zhang Y, Talalay P: Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc Natl Acad Sci USA. 1997, 94 (19): 10367-10372. 10.1073/pnas.94.19.10367.CrossRefPubMedPubMedCentral
52.
go back to reference Finley JW, Ip C, Lisk DJ, Davis CD, Hintze KJ, Whanger PD: Cancer-protective properties of high-selenium broccoli. J Agric Food Chem. 2001, 49 (5): 2679-2683. 10.1021/jf0014821.CrossRefPubMed Finley JW, Ip C, Lisk DJ, Davis CD, Hintze KJ, Whanger PD: Cancer-protective properties of high-selenium broccoli. J Agric Food Chem. 2001, 49 (5): 2679-2683. 10.1021/jf0014821.CrossRefPubMed
Metadata
Title
Selenium enrichment of broccoli sprout extract increases chemosensitivity and apoptosis of LNCaP prostate cancer cells
Authors
Rizky Abdulah
Ahmad Faried
Kenji Kobayashi
Chiho Yamazaki
Eka W Suradji
Kazuto Ito
Kazuhiro Suzuki
Masami Murakami
Hiroyuki Kuwano
Hiroshi Koyama
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2009
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-9-414

Other articles of this Issue 1/2009

BMC Cancer 1/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine